JP2003535133A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003535133A5 JP2003535133A5 JP2002501436A JP2002501436A JP2003535133A5 JP 2003535133 A5 JP2003535133 A5 JP 2003535133A5 JP 2002501436 A JP2002501436 A JP 2002501436A JP 2002501436 A JP2002501436 A JP 2002501436A JP 2003535133 A5 JP2003535133 A5 JP 2003535133A5
- Authority
- JP
- Japan
- Prior art keywords
- depression
- pharmaceutical composition
- weight
- famotidine
- symptoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0002154 | 2000-06-06 | ||
| HU0002154A HUP0002154A3 (en) | 2000-06-06 | 2000-06-06 | Use of famotidine for the preparation of pharmaceutical compositions treating depression or symptoms related with depression |
| PCT/HU2001/000065 WO2001093863A2 (en) | 2000-06-06 | 2001-06-06 | Pharmaceutical compositions for the treatment of depression or symptoms suggesting depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003535133A JP2003535133A (ja) | 2003-11-25 |
| JP2003535133A5 true JP2003535133A5 (https=) | 2010-11-18 |
Family
ID=89978380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002501436A Withdrawn JP2003535133A (ja) | 2000-06-06 | 2001-06-06 | うつ病またはうつ様症状の治療のための医薬組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040010021A1 (https=) |
| EP (1) | EP1289520B1 (https=) |
| JP (1) | JP2003535133A (https=) |
| AT (1) | ATE302000T1 (https=) |
| AU (1) | AU2001266242A1 (https=) |
| DE (1) | DE60112750T2 (https=) |
| DK (1) | DK1289520T3 (https=) |
| ES (1) | ES2247137T3 (https=) |
| HU (1) | HUP0002154A3 (https=) |
| WO (1) | WO2001093863A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8058296B2 (en) * | 2008-11-25 | 2011-11-15 | Richard Tokunaga | Treatment and prevention of deleterious effects associated with alcohol consumption |
| US20150329540A1 (en) | 2012-12-28 | 2015-11-19 | Shin Nippon Biomedical Laboratories, Ltd. | Oct3 activity inhibitor containing imidazopyridine derivative as active component, and oct3 detection agent |
| WO2015002150A1 (ja) | 2013-07-03 | 2015-01-08 | 株式会社新日本科学 | 新規化合物，有機カチオントランスポーター３の検出剤及び活性阻害剤 |
| WO2015163832A1 (en) | 2014-04-25 | 2015-10-29 | Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. | An ibuprofen and famotidine combined composition having improved stability |
| IL311338A (en) * | 2024-03-07 | 2025-10-01 | Ariel Scient Innovations Ltd | Using hyaluronic acid to treat mental disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5460825A (en) * | 1990-05-23 | 1995-10-24 | Mcneil-Ppc, Inc. | Taste mask coatings for preparing chewable pharmaceutical tablets |
| US5352688A (en) * | 1991-02-14 | 1994-10-04 | The Mount Sinai School Of Medicine Of The City University Of New York | Methods for the treatment of bradyphrenia in parkinson's disease |
| WO1995001780A1 (en) * | 1993-07-06 | 1995-01-19 | Merck & Co., Inc. | H2 antagonist-alginate combinations |
| AU7322394A (en) * | 1993-07-06 | 1995-02-06 | Mcneil-Ppc, Inc. | H2 antagonist-sucralfate-antiflatulent combinations |
-
2000
- 2000-06-06 HU HU0002154A patent/HUP0002154A3/hu unknown
-
2001
- 2001-06-06 AT AT01943711T patent/ATE302000T1/de not_active IP Right Cessation
- 2001-06-06 AU AU2001266242A patent/AU2001266242A1/en not_active Abandoned
- 2001-06-06 WO PCT/HU2001/000065 patent/WO2001093863A2/en not_active Ceased
- 2001-06-06 DE DE60112750T patent/DE60112750T2/de not_active Expired - Lifetime
- 2001-06-06 ES ES01943711T patent/ES2247137T3/es not_active Expired - Lifetime
- 2001-06-06 EP EP01943711A patent/EP1289520B1/en not_active Expired - Lifetime
- 2001-06-06 US US10/297,280 patent/US20040010021A1/en not_active Abandoned
- 2001-06-06 JP JP2002501436A patent/JP2003535133A/ja not_active Withdrawn
- 2001-06-06 DK DK01943711T patent/DK1289520T3/da active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2002127804A (ru) | Лекарственная система для лечения осложнений, связанных с диабетом, и невропатии, и их применения | |
| JP2008509224A5 (https=) | ||
| JP2020520963A5 (https=) | ||
| JP2003535133A5 (https=) | ||
| CN115350236A (zh) | 用于管理癌症和治疗癌症并存病的方法 | |
| CN1406609A (zh) | 一种可用于治疗中风和胸痹的中药胶囊剂及其制法 | |
| CN102488768B (zh) | 治疗痛风的中药药物 | |
| PL1778209T3 (pl) | Sposoby i kompozycje do doustnego dostarczania FTS | |
| JP5764655B2 (ja) | 薬物常用癖を治療するための薬剤組成物 | |
| CN100500180C (zh) | 具有祛痰、镇咳、平喘、解热作用的药物组合物 | |
| CN107080786A (zh) | 抗抑郁症药物组合物及其制备方法和应用以及包含其的药物或药物组合物 | |
| WO2004081195A3 (en) | Use of secretin and secretin analogs to treat affective disorders | |
| CN1055239C (zh) | 一种治疗咳喘的药膏及其生产方法 | |
| JP2004262775A5 (https=) | ||
| CA2469702A1 (en) | Darifenacin for use in the treatment of urgency induced by overactive bladder | |
| JP2022011233A (ja) | 下肢疲労改善剤 | |
| Ingenito et al. | S69 Retrospective analysis of physiological response patterns to tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for F508del-CFTR or heterozygous for f508del-CFTR and a residual function mutation | |
| CN1175862C (zh) | 一种治疗痔疮的药物 | |
| Abrams et al. | Smoked cannabis therapy for HIV-related painful peripheral neuropathy: results of a randomized, placebo-controlled clinical trial | |
| CN1045534C (zh) | 去疣组合物 | |
| Hasan et al. | Amyotrophic lateral sclerosis presenting with orthopnea in a patient with COPD and obstructive sleep apnea | |
| JPH10175860A5 (https=) | ||
| CN104208507B (zh) | 一种防治小儿惊风的穴位外敷膏 | |
| TWI224005B (en) | Pharmaceutical composition for nasal spray in treatment of cold and fever and method for producing the same | |
| CN105362739A (zh) | 一种具有安神作用的药物组合物 |